Chinese Traditional and Herbal Drugs
|
2025, 56(20): 7485-7497
Evaluation of effectiveness of Shenmai Injection in treatment of hypoperfusion cerebral infarction based on data integration and network medicine
Full
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.20.019
Outline
Objective Hypoperfusion cerebral infarction (HCI) represents a critical subtype of cerebral infarction, for which current therapeutic strategies exhibit notable limitations. To provide evidence supporting Shenmai Injection (SMI, 参麦注射液)’s efficacy in HCI treatment by integrating multi-source heterogeneous databases and employing network module distance measurement methodologies. Methods Disease targets for HCI were identified using three distinct approaches in open-source databases. The therapeutic potential of SMI was evaluated by comparing its SAB and Z-scores with those of conventional Western drugs and Chinese patent medicines within a protein-protein interaction network, followed by validation of SMI’s prioritized ranking in HCI treatment through a “target-component-herb” pathway analysis integrating PageRank and Hscore algorithms. Results Compared to conventional Western drugs, Chinese patent medicines for cerebral infarction showed generally lower SAB and Z-values. Compared with other Chinese patent medicines, SMI demonstrated superior performance (lower SAB values) in two target-integration methods (Datasets 2 and 3), though this advantage was not consistently observed across all analytical approaches. Among 687 herbs analyzed, Hongshen (Ginseng Radix et Rhizoma Rubra) consistently ranked top 20 in all four datasets, while Maidong (Ophiopogonis Radix) appeared within the top 302. Conclusion SMI may offer particular therapeutic advantages for HCI, especially in cases secondary to chronic cardiac conditions. Its mechanism appears multifactorial, involving not only direct neurorestorative effects but also modulation of fluid shear stress and atherosclerosis pathways, potentially mediated through improved cardiac output and subsequent cerebral perfusion enhancement.
hypoperfusion cerebral infarction
/
Shenmai Injection
/
network medicine
/
multi source heterogeneous database
/
data mining
马鹏珍, 谢晓霞, 庞华鑫, 沈翊康, 胡晓楠, 刘明睿, 梁笑笑, 赵玉凤.
基于数据整合及网络医学的参麦注射液治疗低灌注性脑梗死的有效性评价.
中草药,
2025
, 56
(20)
: 7485
-7497
.
DOI: 10.7501/j.issn.0253-2670.2025.20.019
MA Pengzhen, XIE Xiaoxia, PANG Huaxin, SHEN Yikang, HU Xiaonan, LIU Mingrui, LIANG Xiaoxiao, ZHAO Yufeng.
Evaluation of effectiveness of Shenmai Injection in treatment of hypoperfusion cerebral infarction based on data integration and network medicine[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(20)
: 7485
-7497
.
DOI: 10.7501/j.issn.0253-2670.2025.20.019
Year 2025 volume 56 Issue 20
49
12
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.20.019
- Receive Date:2025-07-13
- Online Date:2026-11-13